Airways reactivity in patients with CF. (Q34773525)

4 August 2017

1 reference

title

Airways reactivity in patients with CF. (English)

1 reference

4 August 2017

Miles Weinberger

1

1 reference

4 August 2017

1 August 2002

1 reference

Clinical Reviews in Allergy & Immunology

4 August 2017

1 reference

4 August 2017

23

1 reference

4 August 2017

1

1 reference

4 August 2017

77-85

1 reference

https://scigraph.springernature.com/pub.10.1385/criai:23:1:077

4 August 2017

0 references

cites work

The effects of albuterol on the lung function of hospitalized patients with cystic fibrosis

1 reference

12 December 2020

Association of cystic fibrosis with allergy

1 reference

12 December 2020

Bronchodilatory effects of salbutamol, ipratropium bromide, and their combination: double-blind, placebo-controlled crossover study in cystic fibrosis

1 reference

12 December 2020

Short-term and long-term effects of albuterol aerosol therapy in cystic fibrosis: a preliminary report

1 reference

12 December 2020

Coexistent respiratory allergy and cystic fibrosis

1 reference

12 December 2020

Genetic factors in nonspecific bronchial hyperreactivity. An epidemiologic study

1 reference

12 December 2020

Bronchial hyperreactivity in cystic fibrosis and asthma

1 reference

12 December 2020

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

1 reference

12 December 2020

Effects of long-acting and short-acting beta-agonists on methacholine dose-response curves in asthmatics

1 reference

12 December 2020

The paradoxical effect of adrenergic and methylxanthine drugs in cystic fibrosis.

1 reference

12 December 2020

Bronchodilator response in adult patients with cystic fibrosis: effects on large and small airways.

1 reference

12 December 2020

Response to aerosol salbutamol, SCH 1000, and placebo in cystic fibrosis

1 reference

12 December 2020

Variability of airways hyper-reactivity and allergy in cystic fibrosis

1 reference

12 December 2020

A controlled trial of long-term bronchodilator therapy in cystic fibrosis

1 reference

12 December 2020

Bronchial allergy in cystic fibrosis

1 reference

12 December 2020

Bronchial vagal tone and responsiveness to histamine, exercise and bronchodilators in adult patients with cystic fibrosis

1 reference

12 December 2020

Controlled Trial of Inhaled Budesonide in Patients with Cystic Fibrosis and Chronic BronchopulmonaryPseudomonas aeruginosaInfection

1 reference

12 December 2020

The effect of ipratropium bromide on lung function in patients with cystic fibrosis

1 reference

12 December 2020

Regular inhaled beta-agonist treatment in bronchial asthma.

1 reference

12 December 2020

Wheezing and airflow obstruction during methacholine challenge in children with cystic fibrosis and in normal children

1 reference

12 December 2020

The inhaled bronchodilators ipratropium bromide and metaproterenol in adults with CF

1 reference

12 December 2020

Mechanisms of bronchial hyperreactivity in cystic fibrosis

1 reference

12 December 2020

Bronchial lability in cystic fibrosis

1 reference

12 December 2020

Prevalence of possible undiagnosed asthma and associated morbidity among urban schoolchildren

1 reference

12 December 2020

The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis

1 reference

12 December 2020

Bronchial reactivity pattern in nonasthmatic parents of asthmatics

1 reference

12 December 2020

Bronchodilators increase airway instability in cystic fibrosis

1 reference

12 December 2020

Prevalence of atopy and exercise-induced bronchial lability in relatives of patients with cystic fibrosis

1 reference

12 December 2020

The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosis

1 reference

12 December 2020

Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort

1 reference

12 December 2020

The effect of high doses of inhaled salbutamol and ipratropium bromide in patients with stable cystic fibrosis

1 reference

12 December 2020

Airway hyperreactivity in cystic fibrosis. Clinical correlates and possible effects on the course of the disease

1 reference

12 December 2020

Effects of standard and high doses of salmeterol on lung function of hospitalized patients with cystic fibrosis

1 reference

12 December 2020

Identifiers

DOI

10.1385/CRIAI:23:1:077

1 reference

PubMed ID

12162108

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

12162108